Literature DB >> 18658148

Multiple membrane-cytoplasmic domain contacts in the cystic fibrosis transmembrane conductance regulator (CFTR) mediate regulation of channel gating.

Lihua He1, Andrei A Aleksandrov, Adrian W R Serohijos, Tamás Hegedus, Luba A Aleksandrov, Liying Cui, Nikolay V Dokholyan, John R Riordan.   

Abstract

The cystic fibrosis transmembrane conductance regulator (CFTR) is a unique ATP-binding cassette (ABC) ion channel mutated in patients with cystic fibrosis. The most common mutation, deletion of phenylalanine 508 (DeltaF508) and many other disease-associated mutations occur in the nucleotide binding domains (NBD) and the cytoplasmic loops (CL) of the membrane-spanning domains (MSD). A recently constructed computational model of the CFTR three-dimensional structure, supported by experimental data (Serohijos, A. W., Hegedus, T., Aleksandrov, A. A., He, L., Cui, L., Dokholyan, N. V., and Riordan, J. R. (2008) Proc. Natl. Acad. Sci. U. S. A. 105, 3256-3261) revealed that several of these mutations including DeltaF508 disrupted interfaces between these domains. Here we have used cysteine cross-linking experiments to verify all NBD/CL interfaces predicted by the structural model and observed that their cross-linking has a variety of different effects on channel gating. The interdomain contacts comprise aromatic clusters important for stabilization of the interfaces and also involve the Q-loops and X-loops that are in close proximity to the ATP binding sites. Cross-linking of all domain-swapping contacts between NBDs and MSD cytoplasmic loops in opposite halves of the protein rapidly and reversibly arrest single channel gating while those in the same halves have lesser impact. These results reinforce the idea that mediation of regulatory signals between cytoplasmic- and membrane-integrated domains of the CFTR channel apparently relies on an array of precise but highly dynamic interdomain structural joints.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18658148      PMCID: PMC2546535          DOI: 10.1074/jbc.M803894200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

1.  Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis.

Authors:  S H Cheng; R J Gregory; J Marshall; S Paul; D W Souza; G A White; C R O'Riordan; A E Smith
Journal:  Cell       Date:  1990-11-16       Impact factor: 41.582

2.  Coordinated clearance of periciliary liquid and mucus from airway surfaces.

Authors:  H Matsui; S H Randell; S W Peretti; C W Davis; R C Boucher
Journal:  J Clin Invest       Date:  1998-09-15       Impact factor: 14.808

3.  Disease-associated mutations in cytoplasmic loops 1 and 2 of cystic fibrosis transmembrane conductance regulator impede processing or opening of the channel.

Authors:  F S Seibert; Y Jia; C J Mathews; J W Hanrahan; J R Riordan; T W Loo; D M Clarke
Journal:  Biochemistry       Date:  1997-09-30       Impact factor: 3.162

4.  Stimulation of CFTR activity by its phosphorylated R domain.

Authors:  M C Winter; M J Welsh
Journal:  Nature       Date:  1997-09-18       Impact factor: 49.962

5.  Impact of the deltaF508 mutation in first nucleotide-binding domain of human cystic fibrosis transmembrane conductance regulator on domain folding and structure.

Authors:  Hal A Lewis; Xun Zhao; Chi Wang; J Michael Sauder; Isabelle Rooney; Brian W Noland; Don Lorimer; Margaret C Kearins; Kris Conners; Brad Condon; Peter C Maloney; William B Guggino; John F Hunt; Spencer Emtage
Journal:  J Biol Chem       Date:  2004-11-03       Impact factor: 5.157

6.  Cytoplasmic loop three of cystic fibrosis transmembrane conductance regulator contributes to regulation of chloride channel activity.

Authors:  F S Seibert; P Linsdell; T W Loo; J W Hanrahan; J R Riordan; D M Clarke
Journal:  J Biol Chem       Date:  1996-11-01       Impact factor: 5.157

7.  Disease-associated mutations in the fourth cytoplasmic loop of cystic fibrosis transmembrane conductance regulator compromise biosynthetic processing and chloride channel activity.

Authors:  F S Seibert; P Linsdell; T W Loo; J W Hanrahan; D M Clarke; J R Riordan
Journal:  J Biol Chem       Date:  1996-06-21       Impact factor: 5.157

8.  Degradation of CFTR by the ubiquitin-proteasome pathway.

Authors:  C L Ward; S Omura; R R Kopito
Journal:  Cell       Date:  1995-10-06       Impact factor: 41.582

9.  Crystal structure of the ATP-binding subunit of an ABC transporter.

Authors:  L W Hung; I X Wang; K Nikaido; P Q Liu; G F Ames; S H Kim
Journal:  Nature       Date:  1998-12-17       Impact factor: 49.962

10.  Diminished self-chaperoning activity of the DeltaF508 mutant of CFTR results in protein misfolding.

Authors:  Adrian W R Serohijos; Tamás Hegedus; John R Riordan; Nikolay V Dokholyan
Journal:  PLoS Comput Biol       Date:  2008-02-29       Impact factor: 4.475

View more
  64 in total

1.  Allosteric modulation balances thermodynamic stability and restores function of ΔF508 CFTR.

Authors:  Andrei A Aleksandrov; Pradeep Kota; Liying Cui; Tim Jensen; Alexey E Alekseev; Santiago Reyes; Lihua He; Martina Gentzsch; Luba A Aleksandrov; Nikolay V Dokholyan; John R Riordan
Journal:  J Mol Biol       Date:  2012-03-08       Impact factor: 5.469

2.  Thermal instability of ΔF508 cystic fibrosis transmembrane conductance regulator (CFTR) channel function: protection by single suppressor mutations and inhibiting channel activity.

Authors:  Xuehong Liu; Nicolette O'Donnell; Allison Landstrom; William R Skach; David C Dawson
Journal:  Biochemistry       Date:  2012-06-15       Impact factor: 3.162

3.  Functional rescue of a misfolded eukaryotic ATP-binding cassette transporter by domain replacement.

Authors:  Raymond J Louie; Silvere Pagant; Ji-Young Youn; John J Halliday; Gregory Huyer; Susan Michaelis; Elizabeth A Miller
Journal:  J Biol Chem       Date:  2010-09-14       Impact factor: 5.157

4.  Positioning of extracellular loop 1 affects pore gating of the cystic fibrosis transmembrane conductance regulator.

Authors:  Daniel T Infield; Guiying Cui; Christopher Kuang; Nael A McCarty
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-12-18       Impact factor: 5.464

5.  Small molecule correctors of F508del-CFTR discovered by structure-based virtual screening.

Authors:  Ori Kalid; Martin Mense; Sharon Fischman; Alina Shitrit; Hermann Bihler; Efrat Ben-Zeev; Nili Schutz; Nicoletta Pedemonte; Philip J Thomas; Robert J Bridges; Diana R Wetmore; Yael Marantz; Hanoch Senderowitz
Journal:  J Comput Aided Mol Des       Date:  2010-10-26       Impact factor: 3.686

6.  The holy grail of cystic fibrosis research: pharmacological repair of the F508del-CFTR mutation.

Authors:  Luigi Maiuri; Daniela De Stefano; Valeria Raia; Guido Kroemer
Journal:  Ann Transl Med       Date:  2015-05

7.  Cooperative assembly and misfolding of CFTR domains in vivo.

Authors:  Kai Du; Gergely L Lukacs
Journal:  Mol Biol Cell       Date:  2009-01-28       Impact factor: 4.138

8.  Structural arrangement of the transmission interface in the antigen ABC transport complex TAP.

Authors:  Giani Oancea; Megan L O'Mara; W F Drew Bennett; D Peter Tieleman; Rupert Abele; Robert Tampé
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-18       Impact factor: 11.205

Review 9.  Dynamics intrinsic to cystic fibrosis transmembrane conductance regulator function and stability.

Authors:  P Andrew Chong; Pradeep Kota; Nikolay V Dokholyan; Julie D Forman-Kay
Journal:  Cold Spring Harb Perspect Med       Date:  2013-03-01       Impact factor: 6.915

10.  Regulation of activation and processing of the cystic fibrosis transmembrane conductance regulator (CFTR) by a complex electrostatic interaction between the regulatory domain and cytoplasmic loop 3.

Authors:  Guangyu Wang; Dayue Darrel Duan
Journal:  J Biol Chem       Date:  2012-10-11       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.